07 Label and store Write the date of reconstitution, concentration, and discard date on the vial
Tesamorelins program was carried through a disciplined clinical development path by Theratechnologies, culminating in Phase 3 trials in HIV-associated lipodystrophy and FDA approval in November 2010
Tesamorelin is a peptide research product supplied by Incline Peps strictly for laboratory and scientific research purposes only
Nearly all medicines in Spain must be purchased at a pharmacy
& Bandmann, O
Common vial strengths: 600 mg, 1,200 mg, 1,500 mg Lyophilized powder requiring reconstitution Single-use sterile glass vials Pharmaceutical-grade products undergo stringent quality control, whereas compounded preparations may vary in purity, stability, and excipient composition